Author: Alan Condon

SpineOvations on Feb 24. finished enrollment for its DiscSeal clinical study in patients suffering from lumbar pain.

Andrew Hecht, MD, is chief of spine surgery at New York City-based Mount Sinai Hospital and Mount Sinai Health System and professor of orthopedic and neurosurgery at the Mount Sinai Medical Center and Icahn School of Medicine.

Wilson Asfora, MD, was terminated by Sanford Health in August after he allegedly violated anti-kickback laws by using medical devices from two companies he owned, reports the Argus Leader. 

Integra LifeSciences posted $395.1 million in reported revenue for the fourth quarter, an increase of 3.1 percent year-over-year.

Konica Minolta Healthcare Americas partnered with RegenLab USA Feb. 19 to distribute its regenerative medicine portfolio for the orthopedic market in the U.S. and Canada.

Here are four spine and neurosurgeons making headlines this week:

In 2015, Zimmer Biomet was established through the merger of Zimmer and Biomet. Two years later, the company appointed Bryan Hanson as president and CEO.

Early-stage research published in npg Regenerative Medicine demonstrated that two medications on the market can enhance the body's ability to heal by releasing stem cells from bone marrow, reports Science Blog.

New York City-based Hospital for Special Surgery partnered with Ivy Rehab Physical Therapy Feb. 21 to launch an orthopedic physical therapy residency program.

The spinal implants and surgery devices market is expected to hit $13.8 billion by 2025, according to a report published by MarketsandMarkets.